APEX MONORAIL
Report
- Report Number
- 2134265-2011-03166
- Event Type
- Injury
- Date Received
- August 11, 2011
- Date of Event
- July 14, 2011
- Report Date
- July 14, 2011
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- LOX
- PMA / PMN Number
- P860019
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE EVALUATED BY MFR: THE COMPLAINT DEVICE WAS NOT RECEIVED FOR ANALYSIS. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).
SAME CASE AS MDR ID: 2134265-2011-03154. IT WAS REPORTED THAT DURING A PERCUTANEOUS CORONARY ANGIOPLASTY TREATMENT PROCEDURE A VESSEL DISSECTION OCCURRED. THE SUB TOTALLY OCCLUDED TARGET LESION BEING TREATED WAS LOCATED IN THE MODERATELY CALCIFIED AND NON TORTUOUS LEFT CIRCUMFLEX (LCX) ARTERY. THE LESION WAS PREDILATED WITH A 2.00X20MM APEX BALLOON CATHETER INFLATED TWICE TO A MAXIMUM OF 12 ATMS. A SMALL DISSECTION MAY HAVE OCCURRED, BUT COULD NOT BE CONFIRMED VIA ANGIOGRAPHY. A 3.00X24MM ION STENT DELIVERY SYSTEM (SDS) WAS THEN ADVANCED TO THE LCX AND WOULD NOT CROSS THE LESION. UPON REMOVAL IT WAS NOTED THAT STENT STRUTS WERE LIFTED OFF OF THE BALLOON. THE LESION WAS AGAIN PREDILATED WITH AN UNSPECIFIED BALLOON AND 3.00X38MM ION SDS WAS ADVANCED TO THE LESION AND DEPLOYED. TIMI 3 FLOW WAS ESTABLISHED AND THE 3.00X38MM ION SUCCESSFULLY TREATED ANY DISSECTION THAT MAY HAVE OCCURRED. NO ADDITIONAL PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS IS FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | APEX MONORAIL | CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS | LOX | BOSTON SCIENTIFIC - MAPLE GROVE | H7493895920200 | 13670491 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Required Intervention |